GENENTECH USA, INC Federal Contracts — Government Award History
Total (All Time)$181M
Latest FY$121M
Primary AgencyDepartment of Health and Human Services
GENENTECH USA, INC has received $181M in total federal contract awards
across 6 fiscal year(s). ▲ 436.5% vs FY2024 Peak year was FY2025 ($121M).
Primary awarding agency: Department of Health and Human Services.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2025 | $121.0M | 9건 | Department of Health and Human Services | |
| FY2024 | $22.6M | 3건 | Department of Health and Human Services | |
| FY2023 | $561,932 | 3건 | Department of Defense | |
| FY2022 | $30.4M | 4건 | Department of Health and Human Services | |
| FY2021 | $682,776 | 3건 | Department of Defense | |
| FY2019 | $5.3M | 8건 | Department of Defense |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2025-09-26 | Department of Health and Human Services | $75.0M | PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS |
| 2025-01-30 | Department of Health and Human Services | $45.1M | OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES |
| 2022-09-14 | Department of Health and Human Services | $30.0M | THE PURPOSE AND NEED FOR THIS PROPOSED REQUIREMENT IS TO PROVIDE THE DIVISION OF |
| 2024-09-30 | Department of Health and Human Services | $22.0M | XOFLUZA (BALOXAVIR MARBOXIL) |
| 2019-09-06 | Department of Defense | $4.3M | 8506792044!OSELTAMIVIR PHOSPHA |
| 2025-05-14 | Department of Defense | $872,421 | 8511378265!OTHER MEDICAL |
| 2020-01-15 | Department of Defense | $648,415 | 8507096058!OTHER MEDICAL |
| 2021-06-22 | Department of Defense | $562,174 | 8508214020!OTHER MEDICAL |
| 2024-05-15 | Department of Defense | $543,592 | 8510632021!OTHER MEDICAL |
| 2023-05-11 | Department of Defense | $541,821 | 8509885034!OTHER MEDICAL |
| 2019-09-05 | Department of Defense | $342,871 | 8506792043!OSELTAMIVIR PHOSPHA |
| 2022-05-18 | Department of Defense | $254,736 | 8509110403!OTHER MEDICAL |
| 2019-09-04 | Department of Defense | $243,163 | 8506792045!OSELTAMIVIR PHOSPHA |
| 2022-09-06 | Department of Justice | $126,984 | ANTIVIRAL MEDICATION FOR PANDEMIC. SPECIFIC TO DOD STOCKPILE WITH EXTENDED EXPIR |
| 2019-09-04 | Department of Defense | $116,303 | 8506792055!OSELTAMIVIR PHOSPHA |
| 2018-09-21 | Department of Defense | $115,960 | 8505904254!OSELTAMIVIR PHOSPHA |
| 2019-09-04 | Department of Defense | $115,284 | 8506792103!OSELTAMIVIR PHOSPHA |
| 2019-09-04 | Department of Defense | $93,573 | 8506792123!OSELTAMIVIR PHOSPHA |
| 2021-02-16 | Department of Justice | $63,492 | TAMIFLU |
| 2020-10-20 | Department of Defense | $57,110 | 4551478369!TAMIFLU 75 MG CAPSULES BLISTER PK/10 |